F2G
Pre-clinicalF2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
Founded
2000
Focus
Small Molecules
About
F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
Funding History
2Total raised: $130.8M
Series B$70MNovo HoldingsMar 15, 2022
Series A$60.8MCowen Healthcare InvestmentsJul 15, 2020
Company Info
TypePrivate
Founded2000
LocationManchester, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile